These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18232005)

  • 1. Effectiveness of the ThinPrep Imaging System: clinical experience in a low risk screening population.
    Papillo JL; St John TL; Leiman G
    Diagn Cytopathol; 2008 Mar; 36(3):155-60. PubMed ID: 18232005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM; DiFurio MJ
    Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
    Elsheikh TM; Kirkpatrick JL; Wu HH
    Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H.
    Difurio MJ; Mailhiot T; Sundborg MJ; Nauschuetz KK
    Diagn Cytopathol; 2010 May; 38(5):313-7. PubMed ID: 19813258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results.
    Srodon M; Parry Dilworth H; Ronnett BM
    Cancer; 2006 Feb; 108(1):32-8. PubMed ID: 16136595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of an imaging system vs. manual screening in the detection of squamous intraepithelial lesions of the uterine cervix.
    Dziura B; Quinn S; Richard K
    Acta Cytol; 2006; 50(3):309-11. PubMed ID: 16780026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the ThinPrep Imaging System in the detection of abnormal cervicovaginal cytology: a practical experience in Korea.
    Ha SY; Lee YK; Oh YL
    Acta Cytol; 2013; 57(2):159-63. PubMed ID: 23406895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia.
    Power P; Gregoire J; Duggan M; Nation J
    J Obstet Gynaecol Can; 2006 Oct; 28(10):884-887. PubMed ID: 17140504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
    Chappell CA; West AM; Kabbani W; Werner CL
    J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSIL/ASC-H (LSIL-H) in cervicovaginal smear: histopathological outcomes and clinical significance.
    Kaygusuz EI; Cetiner H; Sahin D
    Turk Patoloji Derg; 2011 Jan; 27(1):46-50. PubMed ID: 21469426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
    Liman AK; Giampoli EJ; Bonfiglio TA
    Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
    Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
    Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H.
    Hunter C; Duggan MA; Duan Q; Power P; Gregoire J; Nation J
    Cytopathology; 2009 Feb; 20(1):17-26. PubMed ID: 18510551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.